SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 375 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $96,976 | +111.7% | 800,000 | +100.0% | 3.20% | +114.2% |
| Q2 2023 | $45,808 | -55.7% | 400,000 | -46.7% | 1.49% | -53.1% |
| Q1 2023 | $103,373 | -36.2% | 750,000 | -40.0% | 3.18% | -42.8% |
| Q4 2022 | $161,975 | -99.9% | 1,250,000 | -16.7% | 5.56% | +9.4% |
| Q3 2022 | $165,810,000 | +19.6% | 1,500,000 | -18.9% | 5.08% | -15.6% |
| Q2 2022 | $138,676,000 | +29.1% | 1,850,000 | +34.5% | 6.02% | +54.9% |
| Q1 2022 | $107,415,000 | +44.6% | 1,375,000 | +66.7% | 3.88% | +52.2% |
| Q4 2021 | $74,291,000 | +60.7% | 825,000 | +65.0% | 2.55% | +79.3% |
| Q3 2021 | $46,240,000 | -32.2% | 500,000 | +25.0% | 1.42% | -40.5% |
| Q4 2020 | $68,196,000 | -42.9% | 400,000 | -52.9% | 2.39% | -24.0% |
| Q3 2020 | $119,366,000 | +86.1% | 850,000 | +112.5% | 3.15% | -14.2% |
| Q2 2020 | $64,136,000 | -9.6% | 400,000 | -44.8% | 3.67% | -13.4% |
| Q1 2020 | $70,920,000 | -8.4% | 725,000 | +20.8% | 4.24% | +7.5% |
| Q4 2019 | $77,424,000 | +37.1% | 600,000 | -20.0% | 3.94% | +32.6% |
| Q3 2019 | $56,490,000 | -25.6% | 750,000 | +50.0% | 2.97% | -16.1% |
| Q2 2019 | $75,975,000 | +27.5% | 500,000 | 0.0% | 3.54% | +19.3% |
| Q1 2019 | $59,595,000 | +56.0% | 500,000 | +42.9% | 2.97% | +63.9% |
| Q4 2018 | $38,196,000 | +128.8% | 350,000 | +16.7% | 1.81% | +121.8% |
| Q4 2017 | $16,692,000 | -73.7% | 300,000 | -78.6% | 0.82% | -79.7% |
| Q3 2017 | $63,504,000 | +44.9% | 1,400,000 | +7.7% | 4.02% | +88.6% |
| Q2 2017 | $43,823,000 | +9.7% | 1,300,000 | -3.7% | 2.13% | +31.6% |
| Q1 2017 | $39,960,000 | +69.2% | 1,350,000 | +170.0% | 1.62% | -34.5% |
| Q3 2013 | $23,615,000 | – | 500,000 | – | 2.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |